Enfortumab Vedotin and Pembrolizumab — A New Perspective on Urothelial Cancer-Reference-Cited by-同舟云学术

Enfortumab Vedotin and Pembrolizumab — A New Perspective on Urothelial Cancer

Published:2024-03-07 Issue:10 Volume:390 Page:944-946
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Niegisch Günter¹^ORCID

Affiliation:

1. From the Department of Urology, University Hospital and Medical Faculty of the Heinrich Heine University Düsseldorf, and the Center for Integrated Oncology (CIO) Düsseldorf, Düsseldorf, and the CIO Aachen–Bonn–Cologne–Düsseldorf, Cologne — all in Germany.

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMe2400311

Reference11 articles.

1. Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium

2. Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

3. Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

4. Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

5. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma;The Oncologist;2024-08-21

2. OncoFlash-Research Updates in a Flash!;Clinical Oncology;2024-08

3. A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy?;Cancers;2024-06-29

4. Therapie mit ADC plus Pembrolizumab;InFo Hämatologie + Onkologie;2024-04